legislation
-
Senate Bill Proposes Slashing ‘Red Tape’ Around Biosimilar Interchangeability
Legislation introduced by Utah Senator Mike Lee would eliminate testing to show a biosimilar can be substituted for a reference biologic product. Lee contends the current testing requirement adds costs and delays market access for these lower-cost biological medicines.
-
AHA: Legislative action needed to prevent MA plans from harming Medicare beneficiaries
AHA’s report comes after the U.S. House of Representatives passed the Improving Seniors’ Timely Access to Care Act, which would establish several requirements for the prior authorization process under MA plans. But AHA believes additional action is needed by the government.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
MedCity Influencers, Health Tech
Lack of diversity in clinical trials isn’t just a recruiting problem—it’s a data problem
To achieve diversity goals in research requires a multifaceted approach that makes clinical trial participation easier and uses analytics to help identify the right patients to recruit for a clinical trial.
-
MedCity Influencers, Health Tech, Patient Engagement
Now is the time for health tech to capitalize on legislation moves
The onus is on providers, payers and their technology partners to use the new laws and market dynamics as a catalyst to fully achieve digital transformation in healthcare and improve the patient experience.
-
Hospitals, MedCity Influencers, Consumer / Employer, Physicians
No Surprises Act: the Trojan horse of healthcare legislation
This legislation has the potential to drastically reshape the economics of healthcare in America, but it remains unfamiliar to those it affects most—namely, patients, doctors and outpatient surgery centers.
-
Medicare drug price negotiation provision could avoid concerns about stifling innovation
Not all drugs will be subject to price negotiation under the revised legislation. But the agreement sets up a framework enabling Medicare to negotiate the prices of medicines that have been on the market for a long time, and also caps the monthly price of insulin, which has been a flashpoint of drug price debate.
-
Bill aiming to streamline MA prior authorization gains House majority support
The bill, if enacted into law, will establish an electronic prior authorization process and require Medicare Advantage plans to report on their use of prior authorization and the rate of approvals or denials to CMS. It has 227 co-sponsors in the U.S. House, indicating strong support from both Republicans and Democrats.
-
Report: Uninsured rate holds steady at 11% during pandemic despite job losses
The increase in access to public health insurance coverage — via legislation like the Families First Coronavirus Response Act that prevents states from disenrolling Medicaid beneficiaries — helped offset the loss of employer-sponsored insurance, the report from Robert Wood Johnson Foundation shows.
-
More states require telehealth coverage going into 2021
Several states passed recent laws that would require commercial insurance plans to cover more telehealth services on a permanent basis. More states now require health plans to pay the same amount for telehealth as in-person visits.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
New York governor proposes hospital price transparency tool
Governor Andrew Cuomo plans to launch a website where patients can compare the cost of procedures at hospitals around the state.
-
21st Century Cures Act is heavy on mental health
Mental health advocates have described it as the most significant piece of mental health legislation since the 2008 law requiring equal insurance coverage for mental and physical health.
-
21st Century Cures Act passes. Is it a good deal for U.S. taxpayers?
The 21st Century Cures Act, an ambitious bipartisan bill primarily designed to advance medical science and accelerate the introduction of innovative therapeutics to market, cleared the Senate Wednesday.
-
Tech, providers win, while safety, prevention lose in 21st Century Cures Act
The bill is a grab bag for industries that spent plenty of money lobbying to make sure it happened that way.
-
21st Century Cures Act, brought to you by an army of lobbyists
Other than major appropriations bills, a transportation spending bill and an energy infrastructure funding bill, the 21st Century Cures Act garnered more lobbying activity than any of the more than 11,000 bills proposed in the 114th Congress.
-
ACA replacement may not be all that radical
Topping the list of ACA provisions likely to survive under Trump is the requirement that employers cover workers’ children up to the age of 26, analysts said.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
